No Data
Nippon Oil, Nichias etc (additional) Rating
Upgrades - bullish Code Stock Name Securities Company Previous Changed After--------------------------------------------------------------<4967> Kobayashi Pharmaceutical Mizuho "hold" "buy" <6481> THK City "2" "1" <7186> Concordia JPM "Neutral" "OverW" <7202> Isuzu Mizuho "hold" "buy" Downgrades - bearish Code Stock Name Securities Company Previous Changed After-----
List of converted stocks (Part 2) [List of converted stocks for Parabolic Signal]
○ List of stocks to sell on the market Code Stock name Closing price SAR Prime Board <1375> Snow Country Mushroom 1028 1052 <1379> Hokto 1797 1834 <1414> Showa Bond 5293 5416 <1808> Haseko 1825 1880 <1813> Fudo Tetra 2025 2104 <1821> Mitsumi Construction 387 394 <1893> Go Yo Build 610 648 <1926> Wright Works 21 362
SoftBank, 25/3 upward revision operating profit 950 billion yen ← 900 billion yen.
SoftBank <9434> announced a revision to its forecast for the fiscal year ending March 2025. The revenue was revised upward from 6 trillion 200 billion yen to 6 trillion 350 billion yen, and the operating profit from 900 billion yen to 950 billion yen. The strong performance of its subsidiary PayPay, a major player in smart phone payments, as well as the recovery of the mobile business, contributed to this. Positive evaluations for Secom midterm <9735>, Kaken Pharmaceuticals midterm <4521>, Olympus midterm <7733>, Fukui silver revision <8362>, Tokyu midterm <9005>.
Nihon Dempa Kogyo's Strong Half-Year Results Exceed Expectations
Nihon Dempa Kogyo: Confirmatory letter.
Nihon Dempa Kogyo: Half Year Report - Term 84 (2024/04/01 - 2025/03/31)
No Data
No Data